We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Wearable Glucose Monitor Offers Less Invasive Approach to Assessing Diabetes Risk

By HospiMedica International staff writers
Posted on 22 Apr 2025

Diabetes, often referred to as a "silent epidemic," is a growing global health issue with significant impacts on both health and the economy. More...

Detecting impaired glucose regulation early — an intermediate stage between normal blood glucose levels and diabetes — is crucial in preventing or delaying the development of Type 2 diabetes. However, traditional diagnostic methods frequently miss early indicators because they rely on occasional blood samples rather than continuous monitoring. A new study has now introduced a simple, non-invasive method for assessing blood glucose regulation, a critical factor in determining diabetes risk. The approach, which utilizes continuous glucose monitoring (CGM) data, could enhance early detection and risk assessment for diabetes, eliminating the need for blood samples or complex and costly procedures.

Researchers from the University of Tokyo (Tokyo, Japan) aimed to find a practical alternative to traditional diabetes testing methods, which, while helpful, fail to capture the dynamic nature of glucose regulation in normal, everyday conditions. To achieve this, the team turned to CGM, a wearable device that continuously monitors glucose levels in real time, providing a more comprehensive view of blood glucose fluctuations throughout the day. The goal was to develop a CGM-based method to estimate the body's glucose handling capacity — how well it maintains stable glucose levels — without resorting to invasive procedures. The team analyzed data from 64 individuals who had no previous diabetes diagnosis, using CGM devices, oral glucose tolerance tests (OGTT), and clamp tests that assess insulin sensitivity and glucose metabolism. They then validated their results with an independent dataset and mathematical simulations.

Their findings revealed that AC_Var, a measure of glucose fluctuations, strongly correlates with the disposition index, which is a well-known predictor of future diabetes risk. Additionally, their model, which combines AC_Var with glucose standard deviation, proved to be more effective than traditional markers of diabetes, such as fasting blood glucose, HbA1c, and OGTT results, in predicting the disposition index. The researchers also demonstrated that their method was more accurate than conventional diagnostic indicators in predicting diabetes complications, including coronary artery disease. To make this approach more widely accessible, the research team developed a web application that allows individuals and healthcare providers to easily calculate these CGM-based indices.

“By analyzing CGM data with our new algorithm, we identified individuals with impaired glycemic control — even when standard diagnostic tests classified them as ‘normal’. This means we can potentially detect issues much earlier, creating an opportunity for preventive interventions before diabetes is diagnosed,” said Shinya Kuroda, a professor at the University of Tokyo’s Graduate School of Science and co-author of the current study. “Our ultimate goal is to provide a practical, accessible tool for widespread diabetes screening. By enabling early detection of glucose regulation abnormalities, we hope to prevent or delay disease onset and reduce long-term complications.”

Related Links:
University of Tokyo


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Anesthesia Cart
UTGSU-333369-DKB
New
Anesthetic Gas Measurement Module
Scio Four
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.